Dr. Menasché's research focuses on improving the technique and outcome of implanting cardiac cells derived from human embryonic stem cells to treat patients with severe heart failure. Dr. Menasché’s current work looks at optimizing the cardiac differentiation of the embryonic cells and increasing the survival of the grafted cells as well as the transfer methodology by replacing the injections with a cellularized biomaterial to the target area of the epicardium. His team extends this effort to the cell therapy of congenital heart defects of children. It has already been shown that the grafting of cells from the umbilical cord on a specific biomaterial used to repair the right ventricular ejection pathway gives very encouraging results.
A light lunch will be served.
Questions may be directed to Dr. Tim Kamp at email@example.com.